![](/img/cover-not-exists.png)
Adjuvant dendritic cell based immunotherapy (DCBI) after cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) for peritoneal mesothelioma, a phase II single centre open-label clinical trial: rationale and design of the MESOPEC trial
de Boer, Nadine L, van Kooten, Job P, Burger, Jacobus W A, Verhoef, Cornelis, Aerts, Joachim G J V, Madsen, Eva V EVolume:
9
Language:
english
Journal:
BMJ Open
DOI:
10.1136/bmjopen-2018-026779
Date:
May, 2019
File:
PDF, 748 KB
english, 2019